The Ministry of Health announced that over 180,000 vaccines against COVID-19 arrived in Poland on Saturday. The ministry’s spokeswoman said that another 200,000 doses had also been contracted. From December 6, anyone over 12 years of age can sign up for vaccination with Nuvaxovid.
“Today, another 183,000 vaccines against COVID-19 were delivered to Poland, and another 200,000 doses of the vaccine were contracted. We will keep you updated on the date of delivery of this tranche to Poland,” we read in the message sent.
The ministry’s spokeswoman added that the Minister of Health, Izabela Leszczyna, decided to continue the operation of the 989 hotline, through which you can sign up for vaccinations against COVID-19.
– The 989 hotline is a significant convenience for patients – especially those who find it difficult to register for vaccination electronically. Taking into account the voice of public opinion, the Minister of Health decided that the continuation of hotline activities will translate into a real simplification of the registration path, she wrote.
New Nuvaxovid vaccine – for whom?
The vaccine can be taken as the next dose in an already started vaccination series. People who have not yet been vaccinated will receive two more doses three weeks apart. Elderly people, immunocompromised people and medical workers should be vaccinated with another booster dose.
READ ALSO: How to sign up for vaccination?
The next booster dose should be taken especially by people who are at least 60 years old; have reduced immunity or comorbidities that increase the risk of severe COVID-19 (applies to people at least 12 years of age); are health care workers who have direct contact with a patient or infectious material.
Immunocompromised people include patients: undergoing chronic mechanical ventilation; during anticancer treatment; after organ transplants, taking immunosuppressive drugs or biological therapies; having had a stem cell transplant within the last 2 years; with moderate or severe primary immunodeficiency syndromes; with HIV infection; currently treated with high doses of corticosteroids or other drugs that may suppress the immune response; on chronic dialysis due to kidney failure.
Main photo source: Shutterstock